Metoksalen Maco Pharma

Methoxsalen, the active ingredient in Metoksalen Maco Pharma, is a psoralen (photosensitizing agent) presented as a pharmaceutical preparation for extracorporeal use. It is employed in the management of psoriasis and vitiligo in adult patients. GNH USA supplies Metoksalen Maco Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methoxsalen is used as a photosensitizing agent in dermatologic conditions that respond to UVA‑based therapy. - Psoriasis: reduces plaque formation and scaling when combined with controlled UVA exposure. - Vitiligo: promotes repigmentation of depigmented skin areas during PUVA treatment.

Methoxsalen may cause a range of adverse reactions, most of which are related to its photosensitizing properties.

Common Side Effects: - Nausea: mild to moderate stomach upset after administration. - Headache: transient cranial discomfort. - Erythema: redness of skin in treated areas. - Pruritus: itching that may accompany erythema. - Hyperpigmentation: darkening of skin where UVA exposure occurs. - Phototoxic reaction: exaggerated skin response to light.

Serious or Rare Side Effects: - Severe phototoxic burns: extensive skin injury after UVA exposure. - Hepatic dysfunction: abnormal liver enzyme elevations. - Anaphylaxis: rare systemic allergic reaction. - Hemolysis: breakdown of red blood cells, especially in G6PD‑deficient individuals. - Stevens‑Johnson syndrome: severe mucocutaneous eruption. - Bone marrow suppression: rare decrease in blood cell production.

Before initiating therapy with Methoxsalen, several safety considerations should be observed. - Liver function assessment: obtain baseline hepatic enzymes and monitor periodically. - Skin type evaluation: avoid use in patients with severe photosensitivity disorders. - Sun exposure avoidance: instruct patients to limit natural sunlight after dosing. - Concomitant photosensitizers: review all medications that may increase phototoxic risk. - Pregnancy and lactation: use only if clearly indicated after risk‑benefit analysis. - Store at room temperature: keep in original container, protect from moisture and direct light.

Methoxsalen can alter the activity of several other medicines, requiring careful management.

Major Interactions (Avoid): - Warfarin: increased anticoagulant effect, risk of bleeding. - Tetracyclines: enhanced phototoxicity, leading to severe skin reactions. - Thiazide diuretics: additive photosensitivity. - Oral retinoids (e.g., isotretinoin): heightened risk of severe cutaneous reactions. - Phenobarbital: reduced efficacy of Methoxsalen due to enzyme induction.

Moderate Interactions (Monitor Closely): - NSAIDs: may modestly increase phototoxic potential. - Oral contraceptives: possible alteration of hormone levels. - Antihistamines: may mask early signs of phototoxicity. - Antifungal agents (e.g., fluconazole): potential for increased plasma levels. - Vitamin D analogues: monitor for additive skin effects.